Fig. 5
From: Role of nuclear factor-kappa B in feline injection site sarcoma
DHMEQ significantly inhibited cell proliferation in FISS cells, as evaluated by Alamar Blue assays. a FISS-07, FISS-08 and FISS-10 were treated with serial doses of DHMEQ for 72 h in triplicate. Significant inhibitory effects presented at doses of 20 μg/ml and above. Data are presented as means ± SD. *, statistically significant than controls (P < 0.05). b FISS-10 cells were incubated with varying concentrations of DHMEQ for 24, 48 and 72 h. Alamar Blue assays demonstrated dose-dependent growth inhibition of FISS cells in response to DHMEQ treatment